← back to search

Rouven Müller

University Hospital of Zurich ·
Area of research
Hematology · Molecular Biology
Research interest
Research interests include Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Chronic Myeloid Leukemia Treatments, and Protein Degradation and Inhibitors.
h-index
15
citations
933
works
45
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study
The Lancet Haematology 2023cited by 12position: middledoi
inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice
Blood 2016cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jana M. Ellegast · Massachusetts Institute of Technology1 papers (2016–2016)— · 1 papers (2023–2023)Emmanuel Gyan · Sunyani Technical University1 papers (2023–2023)— · 1 papers (2016–2016)Nada Hamad · The Catholic University of Korea St. Vincent's Hospital1 papers (2023–2023)Muhıt Özcan · Ankara University1 papers (2023–2023)Philipp J. Rauch · Novartis (Switzerland)1 papers (2016–2016)Vadim Doronin · Moscow Clinical Scientific Center1 papers (2023–2023)— · 1 papers (2023–2023)— · 1 papers (2023–2023)Laura Maria Fogliatto · Hospital de Clínicas de Porto Alegre1 papers (2023–2023)Anahita Rafiei · University Hospital Frankfurt1 papers (2016–2016)— · 1 papers (2023–2023)Anna Hultberg · Ablynx (Belgium)1 papers (2023–2023)Montserrat Arnán · Universitat de Barcelona1 papers (2023–2023)Fatih Demırkan · Dokuz Eylül University1 papers (2023–2023)— · 1 papers (2023–2023)Andrew H. Wei · CSL (Australia)1 papers (2023–2023)— · 1 papers (2016–2016)Ulrich Wagner · University of Zurich1 papers (2016–2016)